His Confidence interval research incorporates a variety of disciplines, including Hazard ratio and Relative risk. He connects Hazard ratio with Confidence interval in his study. François Dabis's looking at Population as part of his Poisson regression and Rate ratio and Population study. As part of his studies on Poisson regression, he frequently links adjacent subjects like Environmental health. His Environmental health study typically links adjacent topics like Rate ratio. His Cohort study research spans across into fields like Cohort and Prospective cohort study. He conducts interdisciplinary study in the fields of Cohort and Cohort study through his research. Family medicine is integrated with Nursing and Pediatrics in his research. François Dabis merges many fields, such as Nursing and Family medicine, in his writings.
His research investigates the link between Demography and topics such as Population that cross with problems in Environmental health. Environmental health is closely attributed to Population in his research. His Cohort study studies intersect with other disciplines such as Cohort and Prospective cohort study. François Dabis performs integrative study on Cohort and Cohort study in his works. He incorporates Internal medicine and Gastroenterology in his studies. In his works, François Dabis conducts interdisciplinary research on Gastroenterology and Internal medicine. His studies link Family medicine with Human immunodeficiency virus (HIV). His Family medicine study frequently draws connections to other fields, such as Human immunodeficiency virus (HIV). He combines topics linked to Viral disease with his work on Immunology.
While the research belongs to areas of Geometry, François Dabis spends his time largely on the problem of Incidence (geometry), intersecting his research to questions surrounding Optics. His Incidence (geometry) research extends to Optics, which is thematically connected. His research combines Receiver operating characteristic and Internal medicine. His Human immunodeficiency virus (HIV) study frequently involves adjacent topics like Virology. Virology and Human immunodeficiency virus (HIV) are frequently intertwined in his study. His Environmental health study frequently draws connections to adjacent fields such as Child bearing. Child bearing connects with themes related to Population in his study. His Population study frequently draws parallels with other fields, such as Rate ratio. His Rate ratio study frequently draws connections to other fields, such as Environmental health.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)
Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis
Marie-Louise Newell;Hoosen Coovadia;Marjo Cortina-Borja;Nigel Rollins.
The Lancet (2004)
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
P Braitstein;Mwg Brinkhof;F Dabis;M Schechter.
The Lancet (2006)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
Caroline Sabin;Signe Westring Worm;Rainer Weber.
The Lancet (2008)
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf.
The Lancet (2009)
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial
François Dabis;Philippe Msellati;Nicolas Meda;Christiane Welffens-Ekra.
The Lancet (1999)
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis
A Babiker;S Darby;D De Angelis;D Kwart.
The Lancet (2000)
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.
Charlotte Lewden;Geneviève Chene;Philippe Morlat;Francois Raffi.
Journal of Acquired Immune Deficiency Syndromes (2007)
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries
Martin W. G. Brinkhof;François Dabis;Landon Myer;David R. Bangsberg.
Bulletin of The World Health Organization (2008)
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
Amanda Mocroft;Jens D Lundgren;Jens D Lundgren;Miriam Lewis Sabin;Antonella d'Arminio Monforte.
PLOS Medicine (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: